Product
SM-001
1 clinical trial
2 indications
Indication
Major Depressive DisorderIndication
Post-Traumatic Stress DisorderClinical trial
Open-Label Dose-Ranging Study of Oral SM-001 in Healthy AdultsStatus: Not yet recruiting, Estimated PCD: 2024-04-30